MA
Monappa Arun Akhil
About Monappa Arun Akhil
Data last updated:
Monappa Arun Akhil is a Director at Zydus Lifesciences Limited (since 2022) and Director at Zydus Wellness Limited (since 2023). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹30,380 Cr; the largest is Zydus Lifesciences Limited at ₹27,658 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Nov 2022 | 1995 | ₹27,658 Cr (FY 2026) | Active | |
| Director | 17 May 2023 | 1994 | ₹2,722 Cr (FY 2025) | Active |
Board colleagues of Monappa Arun Akhil
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Monappa Arun Akhil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monappa Arun Akhil
Monappa Arun Akhil currently holds 2 directorships: Zydus Lifesciences Limited (Director, since 29 Nov 2022, revenue ₹27,658 Cr (FY 2026)); Zydus Wellness Limited (Director, since 17 May 2023, revenue ₹2,722 Cr (FY 2025)).
Monappa Arun Akhil was first appointed on 29 Nov 2022 as Director at Zydus Lifesciences Limited. The most recent appointment on record is 17 May 2023 at Zydus Wellness Limited.
The 2 current companies of Monappa Arun Akhil that report revenue have a combined latest revenue of ₹30,380 Cr: Zydus Lifesciences Limited ₹27,658 Cr (FY 2026); Zydus Wellness Limited ₹2,722 Cr (FY 2025).
The current boards of Monappa Arun Akhil's companies include Bhadresh Kantilal Shah (Zydus Lifesciences Limited), Dhaval Narendra Soni (Zydus Lifesciences Limited), Ganesh Narayan Nayak (Zydus Lifesciences Limited), Kulin Sanjay Lalbhai (Zydus Lifesciences Limited), Mukesh Mangalbhai Patel (Zydus Lifesciences Limited), Pankaj Ramanbhai Patel (Zydus Lifesciences Limited), among others.